CAFFEINE ANTAGONIZES EEG EFFECTS OF TOBACCO WITHDRAWAL

被引:14
作者
COHEN, C [1 ]
PICKWORTH, WB [1 ]
BUNKER, EB [1 ]
HENNINGFIELD, JE [1 ]
机构
[1] NIDA,ADDICT RES CTR,CLIN PHARMACOL LAB,BALTIMORE,MD 21224
关键词
NICOTINE; CAFFEINE; WITHDRAWAL; EEG;
D O I
10.1016/0091-3057(94)90297-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Six current cigarette smokers and coffee drinkers were given combinations of 0, 150, or 300 mg caffeine and 0, 2, or 4 mg nicotine polacrilex following 12-h nicotine and caffeine abstinence. On one study day, subjects were allowed to smoke cigarettes and to drink caffeinated beverages and no drugs were given. Tobacco and caffeine abstinence impaired performance on the serial addition/subtraction and digit recall tasks; decreased scores on the MBG scale and ratings of ''clear-headed'' and ''quick-witted''; and increased ratings of ''irritability,'' ''muscular tension,'' ''headache,'' ''drowsy,'' ''clumsy,'' ''feeble,'' and ''dreamy.'' The deprivation caused characteristic EEG signs of nicotine withdrawal including increased theta power and decreased alpha frequency. These EEG effects were reversed by cigarette smoking and caffeine administration, but nicotine polacrilex was less effective. Deprivation-induced performance and subjective measures were not changed by administration of nicotine and caffeine combinations.
引用
收藏
页码:919 / 926
页数:8
相关论文
共 38 条
[1]  
[Anonymous], 1988, HLTH CONSEQUENCES SM
[2]  
BATTIG K, 1985, P394
[3]   CAFFEINE AND CIGARETTE-SMOKING - BEHAVIORAL, CARDIOVASCULAR, AND METABOLIC INTERACTIONS [J].
BROWN, CR ;
BENOWITZ, NL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :565-570
[4]   THE PSYCHOPHARMACOLOGICAL AND ELECTROPHYSIOLOGICAL EFFECTS OF SINGLE DOSES OF CAFFEINE IN HEALTHY-HUMAN SUBJECTS [J].
BRUCE, M ;
SCOTT, N ;
LADER, M ;
MARKS, V .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (01) :81-87
[5]   EFFECTS OF CAFFEINE ON CIGARETTE-SMOKING AND SUBJECTIVE RESPONSE [J].
CHAIT, LD ;
GRIFFITHS, RR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :612-622
[6]  
Cochran W.G, 1957, STAT METHODS, V6th ed
[7]  
Edwards JA, 1983, PHARMACOL THERAPEUT, V19, P147
[9]  
Gilbert R. M., 1976, RES ADV ALCOHOL DRUG, P49
[10]  
GRIFFITHS RR, 1990, J PHARMACOL EXP THER, V255, P1123